Overview

Pantoprazole in Cisplatin Nephrotoxicity

Status:
Recruiting
Trial end date:
2030-12-30
Target enrollment:
Participant gender:
Summary
Pantoprazole in Cisplatin Nephrotoxicity
Phase:
Phase 3
Details
Lead Sponsor:
Sherief Abd-Elsalam
Treatments:
Cisplatin
Pantoprazole